TNFRSF8 and neoplasm: When the tumor volume reached approximately 100 mm3, CD5-CD30-MU-CAR-T cells, conventional CD5-CD30-CAR-T cells, SdΔN17-28BBZ3-expressing CD8+ T cells or control CD8+ T cells were adoptively transferred into NCG mice via tail vein injection respectively.